PLA results from tumor tissue samples indicate that HER2 heterodimerization with EGFR and HER3 proteins is decreased in both the treatment group of SA-5 alone and SA-5-Dox-LP as compared to the control group (Figure 8). Here, ERBB2 is linked to neoplasm.